North America Contraceptive Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Contraceptive Devices Market Size

• The North America Contraceptive Devices Market was valued atUSD9.1 Billionin 2024and is expected to reachUSD13.70 Billionby 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at aCAGR of 5.2%primarily driven by the anticipated launch of therapies
• The drivers of the Contraceptive Devices Market include the rising awareness about family planning and reproductive health, increasing government initiatives to promote contraceptive use, and the growing demand for effective and convenient birth control methods..

North America Contraceptive Devices Market Analysis

• Contraceptive devices play a crucial role in reproductive health management by enabling individuals and couples to prevent unintended pregnancies and plan families effectively. These devices are essential tools in reducing maternal mortality, improving child health outcomes, and enhancing women's participation in the workforce and education.
• The demand for contraceptive devices in North America is driven by increased awareness about sexual health, rising incidence of unintended pregnancies, and supportive governmental policies promoting family planning initiatives. Additionally, the growing acceptance of long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants, is propelling market growth.
• North America stands as a dominant region in the global contraceptive devices market, supported by its advanced healthcare systems, high levels of public and private sector investment in women's health, and the presence of major industry players. The United States, in particular, has seen robust efforts from healthcare organizations and advocacy groups aimed at increasing access to a wide range of contraceptive options.

• For instance, as of 2023, nearly 65% of women aged 15–49 in the United States were using some form of contraception, with IUD usage accounting for a significant and growing portion of this demographic.

• Globally, contraceptive devices such as IUDs, condoms, and subdermal implants rank among the most effective and widely used birth control methods. In North America, their availability and accessibility are continually enhanced through healthcare reforms, public health programs, and growing consumer preference for non-hormonal and minimally invasive options

Report ScopeContraceptive DevicesMarket Segmentation  

Contraceptive Devices Market Trends

“Increased Adoption of Long-Acting and Non-Hormonal Contraceptive Solutions”

• Rising Preference for Long-Acting Reversible Contraceptives (LARCs): A growing number of women are opting for IUDs and implants due to their long-term efficacy, low maintenance, and reduced risk of user error compared to short-term methods like pills and condoms.
• Shift Toward Non-Hormonal Options: There's increasing demand for hormone-free contraceptive devices, such as copper IUDs, driven by consumer concerns over hormonal side effects and a preference for natural alternatives.

Contraceptive Devices Market Dynamics

Driver

“High Awareness and Access to Family Planning Services”

• Government and NGO-Led Initiatives: Federal and state-level programs in the U.S. and Canada, such as Title X in the U.S., are expanding access to affordable contraceptive services, significantly driving market growth.
• https://opa.hhs.gov/title-x-family-planning
• Growing Demand for Modern Contraceptive Methods: The continued emphasis on sexual wellness, education, and proactive reproductive health is leading to higher adoption of modern and effective contraceptive devices across demographics.
• Widespread Availability in Retail and Online Pharmacies: The ease of access through retail outlets and e-commerce channels is increasing user convenience and boosting sales of over-the-counter contraceptive devices such as condoms and emergency contraception.

Opportunity

“Technological Advancements and Telehealth Expansion”

• Smart Contraceptive Devices and Apps: Integration of digital technologies with contraceptive methods (e.g., fertility tracking apps paired with devices) is opening new market segments for tech-enabled family planning solutions.
• Increased Access Through Policy Reform: Policy improvements, including expanded Medicaid coverage and employer-provided health plans, offer new opportunities for growth and greater consumer access to a variety of contraceptive options.
• For instance, under the Affordable Care Act, most health insurance plans are required to cover FDA-approved contraceptive methods without charging a copayment or coinsurance.
• https://www.hrsa.gov/womens-guidelines

Restraint/Challenge

“Cultural Sensitivities and Access Inequities”

• Social and Religious Barriers: In certain regions and communities, cultural or religious opposition to contraceptive use can hinder adoption, particularly of long-term or invasive devices.
• Disparities in Insurance and Healthcare Access: Despite overall availability, unequal access to insurance coverage and healthcare services—especially among low-income or rural populations—continues to limit equitable adoption of contraceptive devices.

Contraceptive Devices Market Scope

The market is segmented on the basis, product type, technology, and distribution channel.

Contraceptive Devices Market Regional Analysis

“U.S. is the Dominant Country in the Contraceptive Devices Market”

• North America leads the global Contraceptive Devices market, fueled by a robust healthcare infrastructure, widespread access to modern contraceptive options, and strong presence of major industry players such as CooperSurgical, Bayer, and Church & Dwight.
• The United States holds a substantial market share, driven by high awareness of reproductive health, supportive government policies including Title X and ACA contraceptive mandates, and rising demand for long-acting reversible contraceptives (LARCs) like IUDs and implants.
• Comprehensive insurance coverage, including no-cost access to FDA-approved contraceptive methods under the Affordable Care Act (ACA), significantly boosts product adoption and utilization across diverse population groups.
• Ongoing research & development investments, combined with increasing integration of contraceptive counseling into digital and telehealth platforms, are accelerating the adoption of user-friendly, personalized, and tech-integrated birth control solutions

“Canada is Projected to Register the Highest Growth Rate”

• Canada is witnessing steady growth in the Contraceptive Devices market, supported by a universal healthcare system, strong public health policies, and increasing emphasis on sexual and reproductive health education.
• Government-led initiatives, such as expanded access to contraceptives through provincial health plans and youth-focused sexual health programs, are driving wider adoption of both hormonal and non-hormonal contraceptive methods across the country.
• Urban centers such as Toronto, Vancouver, and Montreal are leading in the uptake of long-acting reversible contraceptives (LARCs) like IUDs and implants, reflecting a shift toward user-friendly, effective, and low-maintenance birth control options.
• With growing advocacy for reproductive rights, rising educational levels, and increased availability of digital health platforms offering contraceptive counseling, Canada is poised to become a more significant contributor to the North American contraceptive devices market

Contraceptive Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• CooperSurgical, Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Bayer AG (Germany)
• AbbVie Inc. (U.S.)
• Medicines360 (U.S.)
• Veru Inc. (U.S.)
• Reckitt Benckiser Group plc (U.K.)
• Church & Dwight Co., Inc. (U.S.)

Latest Developments in Global Contraceptive Devices Market

• In September 2023, Medicines360, a rare nonprofit pharma, spent $82 million to bring a $50 hormonal IUD, Liletta, to market. Despite hurdles like FDA regulations, funding challenges, and market resistance, it expanded access for low-income women, saving the U.S. healthcare system $100 million and sparking ongoing legislative efforts for nonprofit drug development.
• https://toronto.citynews.ca/2023/09/01/medicines360s-long-and-winding-82-million-road-to-create-and-distribute-50-birth-control/
•  In January 2024, Medicines360, a nonprofit women’s health pharmaceutical organization, in partnership with Theramex, announced the commercial launch of LILETTA® (levonorgestrel-releasing intrauterine system) in Canada. This milestone expands access to long-acting reversible contraceptives (LARCs) for Canadian women, aligning with public health efforts to improve reproductive health options and equity.

SKU-1181